Evidence map›Paper›PMID 41981279›Full record

ArticleCommunications biology2026

Tiki2 restrains Wnt5a/Ror signaling to limit inflammation in acute kidney injury.

Cui Yang, Shujie Wang, Mei Zhang, Bryan T MacDonald, Zheng Wang, Xi He, Rui Zeng, Xinjun Zhang

Abstract read
In one paragraph

Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Cui Yang *Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, China.
Shujie Wang *Division of Nephrology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Mei ZhangGenetic Diseases Key Laboratory of Sichuan Province, Medical Genetics and Rare Diseases Center, Department of Laboratory Medicine, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Bryan T MacDonaldThe F. M. Kirby Neurobiology Center, Boston Children's Hospital, Department of Neurology, Harvard Medical School, Boston, MA, USA.
Zheng WangDivision of Nephrology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Xi HeThe F. M. Kirby Neurobiology Center, Boston Children's Hospital, Department of Neurology, Harvard Medical School, Boston, MA, USA. xi.he@childrens.harvard.edu.ORCID http://orcid.org/0000-0002-8093-7981
Rui ZengDivision of Nephrology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. zengrui@tjh.tjmu.edu.cn.ORCID http://orcid.org/0000-0003-1808-9755
Xinjun ZhangGenetic Diseases Key Laboratory of Sichuan Province, Medical Genetics and Rare Diseases Center, Department of Laboratory Medicine, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China. xzhang@uestc.edu.cn.ORCID http://orcid.org/0000-0003-2409-4104

Funding

Department of Science and Technology of Sichuan Province (Sichuan Provincial Department of Science and Technology) 2024NSFSC0675National Natural Science Foundation of China (National Science Foundation of China) 81870620National Natural Science Foundation of China (National Science Foundation of China) 81974086National Natural Science Foundation of China (National Science Foundation of China) 82370699
6 · The paper itself

Abstract

Ischemia/reperfusion (IR)-induced acute kidney injury (AKI) occurs in a range of clinical settings and is characterized by pronounced inflammation, but the underlying regulatory mechanisms remain incompletely understood. Tiki2 is a Wnt inhibitor that is highly expressed in the kidney and its function has not been defined. Here, we show that Tiki2 is enriched in proximal tubular epithelial cells (PTECs) and is dynamically regulated during IR-induced AKI. Tubule-specific ablation of Tiki2 exacerbates immune cell infiltration and tubular injury following IR. Mechanistically, loss of Tiki2 leads to increased activation of Wnt5a/Ror signaling, which is induced in PTECs after IR injury, resulting in increased JNK and ERK activation and elevated expression of chemokines and cytokines that promote the infiltration of immune cells. Notably, the aggravated injury and inflammation caused by Tiki2 deficiency are reversed by Ror2 knockdown in PTECs. Together, these findings identify Tiki2 as a negative regulator of Wnt5a/Ror signaling in renal tubular cells and highlight the Tiki2-Wnt5a/Ror axis as a potential therapeutic target in IR-induced AKI.

Indexed as

Acute Kidney InjuryInflammationReceptor Tyrosine Kinase-like Orphan ReceptorsWnt-5a ProteinAnimalsEpithelial CellsHumansKidney Tubules, ProximalMaleMiceReperfusion InjurySignal TransductionReceptor Tyrosine Kinase-like Orphan ReceptorsRor2 protein, mouseWnt-5a ProteinWnt5a protein, mouse

Identifiers

PMID41981279
PMCPMC13263348

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.